+
+
DNA-Tethered Hoechst GrooVe-Binding Agents
J. Am. Chem. Soc., Vol. 118, No. 30, 1996 7057
(83% yield). Rf (dichloromethane/methanol, 7:3, + trace of tri-n-
butylamine): 0.36. 1H-NMR (DMSO-d6): δ ) 2.10 (s, 3H, NCH3),
3.00 (s, 4H, -CH2-), 3.10 (s, 4H, -CH2-), 5.60 (s, 2H, -NH2), 6.4-
8.2 (m, 10 H, Ar H). UV (H2O): λmax 272, 342, λmin 254, 298 nm. IR
(KBr): 2933, 2808, 1608, 1439, 1491, 1280, 1234, 1178, 1140, 1005,
963, 832 cm-1. HRMS: calcd for C25H26N7 (M + H+), 424.224 97,
found 424.224 50.
330 nm, λmin 296 nm. HRMS: calcd for C29H29N7O2F3 (M + H+),
564.233 48, found 564.232 30.
2-[4-(2-Aminoethoxy)phenyl]-6-benzimidazolyl]-6-(1-methyl-4-
piperazinyl)benzimidazole (8). The trifluoroacetamide 7 (140 mg,
0.248 mmol) was dissolved in 10 mL of potassium carbonate in
methanol and water (5:2, v/v). The turbid solution was heated gently
until a clear solution resulted and then allowed to stir overnight at
ambient temperature. TLC analysis at this point indicated that the
starting material was absent and a new fluorescent spot was present.
The solvents were removed, and the residue 8 was purified by flash
chromatography on silica gel (dichloromethane with a gradient of
methanol containing trace amounts of tri-n-butylamine to yield 110
mg of 8 (0.235 mmol) 94%. Rf (dichloromethane/methanol, 1:1,
containing a trace of tri-n-butylamine): 0.18. 1H-NMR (DMSO-d6):
δ ) 2.2 (s, 3H, -CH3), 2.4-2.8 (m, 8H, -CH2-), 3.0 (t, 2H,
-CH2-), 4.0 (t, 2H, -CH2-), 5.4 (s, 2H, -NH2), 6.9 (d, 2H, Ar H),
7.1 (d, 2H, Ar H), 7.4 (d, 1H, Ar H), 7.6 (d, 2H, Ar H), 7.9 (d, 1H, Ar
H), 8.2 (d, 2H, Ar H), 8.24 (s, 1H, Ar H) ppm. UV (methanol): λmax
254, 330 nm, λmin 296 nm. HRMS: calcd for C27H30N7O (M + H+),
468.251 18, found 468.251 30.
2-[2-[4-[2-(Bromoacetamido)ethoxy]phenyl]-6-benzimidazolyl]-
6-(1-methyl-4-piperazinyl)benzimidazole (9). To 50 mg (0.107
mmol) of 8 dissolved in 3 mL of anhydrous DMF was added ∼1 mg
of 4-(N,N-dimethylamino)pyridine, and the solution was cooled to -78
°C. To the cooled solution was added 56 mg (0.214 mmol) of
bromoacetic anhydride, and the reaction mixture was stirred for 3 h at
-78 °C. TLC analysis after 3 h indicated the absence of starting
material and the presence of a new compound. The reaction was
quenched with methanol, and the mixture was reduced in volume. Ether
was added, and the resulting precipitate was collected and purified by
column chromatography on silica gel using a gradient of dichloro-
methane/methanol containing a trace amount of tri-n-butylamine to yield
35 mg (0.059 mmol, 56%) of 9. Rf (dichloromethane/methanol, 7:3,
containing a trace of tri-n-butylamine): 0.52. 1H-NMR (DMSO-d6):
δ ) 2.2 (s, 3H, -CH3), 3.2-3.6 (m, 8H, -CH2-), 3.8 (t, 2H,
-CH2-), 4.2 (t, 2H, -CH2-), 4.4 (s, 2H, -CH2-), 7.0-8.4 (m, 10H,
Ar H), 9.0 (s, 1H, NH) ppm. UV (methanol): λmax 255, 335 nm, λmin
295 nm. HRMS: calcd for C29H31N7O2Br (M + H+), 588.172 26,
found 588.171 40.
Synthesis of Oligonucleotides Tethering a Masked Thiol Group
(10). DNA sequences were initially assembled using phosphoramidite
protocols.37 At the site of the tether, 25 µmol of the appropriate fully
protected nucleoside H-phosphonate was dissolved in 600 µL of 1:1
anhydrous acetonitrile/pyridine and activated by the addition of 25 µmol
of adamantanecarbonyl chloride.38,39 The column was removed from
the synthesizer and the activated monomer was added using a syringe.
The column was then rinsed with 1:1 anhydrous pyridine/acetonitrile,
followed by acetonitrile, and was then dried in a desiccator under high
vacuum. The N-(triphenylacetyl)cystamine linker was then added as
described.40 The remaining monomers were added using standard
phosphoramidite protocols, but the capping steps were deleted.40 After
removal of the terminal DMT group, the sequences were deprotected
(concentrated ammonia for 6 h at 50 °C), and the diastereomeric
sequences were separated and isolated using a 9.4 × 250 mm column
of ODS-Hypersil at a flow rate of 3.0 mL/min in 20 mM potassium
phosphate (pH 5.5) with a gradient of methanol (0-100% over 90 min),
desalted (Sephadex G-10), and lyophylized to dryness.
Oligonucleotide Conjugation. To 1 A260 unit of a single diastereo-
mer of the desired dodecamer in 100 mM Tris‚HCl, pH 8, was added
DTT to a concentration of 10 mM, and the mixture was incubated at
50 °C for 1 h. HPLC analysis [50 mM triethylammonium acetate, pH
7.0, with a linear gradient of acetonitrile (7-28% over 30 min)] after
this time period indicated the complete absence of the (triphenylmethyl)-
acetyl-protected sequence (retention time ∼28 min) and the presence
2-[2-[4-(Bromoacetamido)phenyl]-6-benzimidazolyl]-6-(1-methyl-
4-piperazinyl)benzimidazole (5). To 0.1 g (0.236 mmol) of 2-[2-(4-
aminophenyl)-6-benzimidazolyl]-6-(1-methyl-4-piperazinyl)benz-
imidazole (4) dissolved in a mixture of DMF/dichloromethane (1:1,
v/v) (4 mL) cooled to -78 °C was added 0.26 mL (0.472 mmol) of
bromoacetic anhydride followed by 0.028 g (0.023 mmol) of 4-(N,N-
dimethylamino)pyridine. The reaction mixture was stirred at -78 °C
for 3 h. TLC analysis (dichloromethane/methanol, 7:3, + trace tri-n-
butylamine) indicated the completion of the reaction. Methanol (1 mL)
and then water (1 mL) were added at -78 °C to destroy any unreacted
bromoacetic anhydride. The solvents were evaporated, and the residue
was dissolved in the minimum amount of methanol and added to ether.
The resulting yellow precipitate was filtered and washed thoroughly
with ether. The resulting yellow solid was purified on a small column
of silica gel using a gradient of dichloromethane and methanol. The
pooled fractions were evaporated to yield 0.098 g (0.234 mmol) of 5
(97% yield). Rf (dichloromethane/methanol, 7:3, + trace of tri-n-
butylamine): 0.52. 1H-NMR (DMSO-d6): δ ) 2.25 (s, 3 H, NCH3),
2.50 (m, 8 H, -CH2-), 4.25 (s, 2 H, bromoacetyl H), 6.95 (d, 1 H, Ar
H), 7.05 (s, 1 H, Ar H), 7.45 (d, 1 H, Ar H), 7.71 (d, 1 H, Ar H), 7.82
(d, 2 H, Ar H), 8.04 (d, 1 H, Ar H), 8.19 (d, 2 H, Ar H), 8.38 (s, 1 H,
Ar H), 10.43 (s, 1 H, amido H) ppm. The imidazole NH residues could
not be located under these solvent conditions. The amide resonance
at 10.43 ppm was exchangeable. UV (H2O): λmax 268, 345 nm, λmin
245, 296 nm. HRMS: calcd for C27H27N7BrO (M + H+), 544.146 04,
found 544.144 00.
2-[2-[4-[2-(Trifluoroacetamido)ethoxy]phenyl]-6-benzimidazolyl]-
6-(1-methyl-4-piperazinyl)benzimidazole (7). 4-[2-(Trifluoroacet-
amido)ethoxy]benzonitrile was prepared by the condensation of (tert-
butoxycarbonyl)ethanolamine with 4-cyanophenol using a Mitsonobu
protocol.35 The tert-butoxycarbonyl group was removed by passing
HCl(g) through the crude product dissolved in dichloromethane, and
the resulting amine was protected with trifluoroacetic anhydride in
quantitative yield using a standard literature procedure.36
To prepare the necessary imino methyl ester 6, 1.2 g (4.65 mmol)
of 4-[2-(trifluoroacetamido)ethoxy]benzonitrile was dissolved in 15 mL
of dichloromethane, 0.267 g (8.37 mmol) of anhydrous methanol was
added, and the reaction was cooled to 0 °C. The reaction mixture was
saturated with HCl(g) and maintained at 0 °C overnight. The resulting
white precipitate was collected, washed thoroughly with diethyl ether,
and dried to yield 1.3 g (4.40 mmol, 96%) of a white solid which was
used in the following step without purification.
To 100 mg (0.310 mmol) of 2-(3,4-diaminophenyl)-6-(1-methyl-4-
piperazinyl)benzimidazole (1)33 dissolved in 3 mL of anhydrous
methanol was added 134 mg (0.465 mmol) of 4-[2-(trifluoroacetamido)-
ethoxy]benzimidic acid methyl ester followed by 37 µL (∼0.6 mmol)
of glacial acetic acid. The mixture was stirred at 65-70 °C for 3 h.
At this time, TLC analysis (dichloromethane/methanol, 7:3, containing
a trace of tri-n-butylamine) indicated the absence of starting material
and the presence of a new compound that was fluorescent under long-
wavelength UV excitation (365 nm). Solvents were removed by
evaporation, the residue was dissolved in a minimum amount of
methanol, and the solution was neutralized with ammonium hydroxide.
The resulting brown precipitate was collected and purified by silica
gel column chromatography (dichloromethane and a gradient of
methanol, containing a trace amount of tri-n-butylamine) to yield 80
mg (0.138 mmol, 45%) of 7. Rf (dichloromethane/methanol, 7:3,
containing a trace of tri-n-butylamine): 0.38. 1H-NMR (DMSO-d6):
δ ) 2.2 (s, 3H, CH3), 3.0-3.2 (m, 8H, -CH2-), , 3.6 (t, 2H,
-CH2-), 4.2 (t, 2H, -CH2-), 6.9 (d, 2H, Ar H), 7.1 (d, 2H, Ar H),
7.4 (s, 1H, Ar H), 7.6 (s, 1H, Ar H), 7.9 (d, 1H, Ar H), 8.2 (d, 2H, Ar
H) 8.3 (s, 1H, Ar H), 9.8 (s, 1H, NH) ppm. UV (methanol): λmax 254,
(37) Matteucci, M. D.; Caruthers, M. H. J. Am. Chem. Soc. 1981, 103,
3185-3191.
(38) Froehler, B. C.; Ng, P. G.; Matteucci, M. D. Nucleic Acids Res.
1986, 14, 5399-5407.
(39) Froehler, B. C.; Matteucci, M. D. Tetrahedron Lett. 1986, 27, 469-
472.
(35) Mitsunobu, O. Synthesis 1981, 1-28.
(36) Pyne, S. G. Tetrahedron Lett. 1987, 28, 4737-4741.
(40) O’Donnell, M. J.; Hebert, N.; McLaughlin, L. W. Biol. Med. Chem.
Lett. 1994, 4, 1001-1004.